Research Article
Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels
Table 1
Main characteristics and methodological quality of eligible studies.
| | First author | Year | Country | Ethnicity | Total | Sample size | Gender (M/F) | Age (days) | Disease | Method | NOS | | Atorvastatin | Control | Atorvastatin | Control | Atorvastatin | Control |
| | Zhuo [22] | 2013 | China | Asians | 206 | 104 | 102 | 61/43 | 55/47 | 64.0 ± 10.0 | 61.0 ± 13.0 | AF | ELISA | 8 | | Wang [25] | 2011 | China | Asians | 98 | 50 | 48 | — | — | 55.6 ± 10.7 | 55.6 ± 10.7 | PAF | ELISA | 6 | | Guo [23] | 2011 | China | Asians | 87 | 45 | 42 | — | — | 60.2 ± 8.3 | 60.2 ± 8.3 | PAF | ELISA | 6 | | Demir [21] | 2011 | Turkey | Asians | 44 | 22 | 22 | 10/12 | 13/9 | 62.0 ± 9.0 | 60.0 ± 10.0 | PAF | INA | 7 | | Dong [26] | 2009 | China | Asians | 81 | 41 | 40 | 25/16 | 26/14 | 56.0 ± 15.2 | 56.0 ± 15.2 | AF | ELISA | 7 | | Yuan [27] | 2008 | China | Asians | 162 | 83 | 79 | 50/33 | 51/28 | 58.0 ± 11.2 | 58.0 ± 11.2 | AF | INA | 8 | | Ozaydin [10] | 2006 | Turkey | Asians | 48 | 24 | 24 | 17/7 | 12/12 | 61.0 ± 13.0 | 64.0 ± 9.0 | AF | ELISA | 7 |
|
|
M: male; F: female; NOS: Newcastle-Ottawa Scale; PAF: paroxysmal atrial fibrillation; AF: atrial fibrillation; ELISA: enzyme linked immunosorbent assay; INA: immunoturbidimetry.
|
